Literature DB >> 22792882

Appearance concerns and psychological distress among HIV-infected individuals with injection drug use histories: prospective analyses.

Aaron J Blashill1, Janna R Gordon, Steven A Safren.   

Abstract

Morphologic alterations in body composition are common among HIV-infected individuals, and these changes are associated with increased appearance concerns. Previous cross-sectional data indicate that appearance concerns among HIV-infected individuals are related to increased levels of psychological distress. However, to date, no known prospective data have been published on these relationships. The purpose of the current study was to address the temporal prediction of appearance concerns on depression and anxiety severity. Data were culled from a prospective, randomized controlled trial of cognitive behavioral therapy for depression and medication adherence in individuals with a history of injection drug use (IDU). Participants were 89 HIV-infected individuals who were randomized to either a cognitive behavioral therapy or treatment as usual condition. Linear mixed-level modeling revealed elevated levels of appearance concerns were prospectively related to increased depression and anxiety, as rated by both clinician-administered and self-report measures. Appearance concerns among depressed, IDU, HIV-infected individuals are associated with changes in psychological distress. Psychosocial interventions should consider the role of appearance as it relates to psychological functioning.

Entities:  

Mesh:

Year:  2012        PMID: 22792882      PMCID: PMC3426195          DOI: 10.1089/apc.2012.0122

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  27 in total

1.  Disclosure of HIV status and psychological well-being among Latino gay and bisexual men.

Authors:  María Cecilia Zea; Carol A Reisen; Paul J Poppen; Fernanda T Bianchi; John J Echeverry
Journal:  AIDS Behav       Date:  2005-03

Review 2.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

3.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

4.  Development of the Impact of Weight Loss Scale (IWLS): a psychometric study in a sample of men with HIV/AIDS.

Authors:  G J Wagner; J G Rabkin
Journal:  AIDS Care       Date:  1999-08

Review 5.  Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes.

Authors:  Aaron J Blashill; Nicholas Perry; Steven A Safren
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

6.  Prevalence and impact of body physical changes in HIV patients treated with highly active antiretroviral therapy: results from a study on patient and physician perceptions.

Authors:  Esther Cabrero; Laura Griffa; Angel Burgos
Journal:  AIDS Patient Care STDS       Date:  2010-01       Impact factor: 5.078

7.  Body image in older men with or at-risk for HIV infection.

Authors:  A Sharma; A A Howard; R S Klein; E E Schoenbaum; D Buono; M P Webber
Journal:  AIDS Care       Date:  2007-02

8.  Antiretroviral therapies associated with lipoatrophy in HIV-infected women.

Authors:  Phyllis C Tien; Yolanda Barrón; Jessica E Justman; Charles Hyman; Mardge H Cohen; Mary Young; Andrea Kovacs; Stephen R Cole
Journal:  AIDS Patient Care STDS       Date:  2007-05       Impact factor: 5.078

9.  Body image satisfaction in heterosexual, gay, and lesbian adults.

Authors:  Letitia Anne Peplau; David A Frederick; Curtis Yee; Natalya Maisel; Janet Lever; Negin Ghavami
Journal:  Arch Sex Behav       Date:  2008-08-19

10.  Severity of lipodystrophy is associated with decreased health-related quality of life.

Authors:  Giovanni Guaraldi; Rita Murri; Gabriella Orlando; Chiara Giovanardi; Nicola Squillace; Marcella Vandelli; Barbara Beghetto; Giulia Nardini; Maria De Paola; Roberto Esposito; Albert W Wu
Journal:  AIDS Patient Care STDS       Date:  2008-07       Impact factor: 5.078

View more
  7 in total

1.  Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use.

Authors:  Aaron J Blashill; Janna R Gordon; Steven A Safren
Journal:  J Behav Med       Date:  2012-11-22

2.  Barriers and facilitators to engagement in lifestyle interventions among individuals with HIV.

Authors:  Bernadette Capili; Joyce K Anastasi; Michelle Chang; Olugbenga Ogedegbe
Journal:  J Assoc Nurses AIDS Care       Date:  2014-03-12       Impact factor: 1.354

3.  Cognitive behavioral therapy for body image and self-care (CBT-BISC) in sexual minority men living with HIV: A randomized controlled trial.

Authors:  Aaron J Blashill; Steven A Safren; Sabine Wilhelm; Jonathan Jampel; S Wade Taylor; Conall O'Cleirigh; Kenneth H Mayer
Journal:  Health Psychol       Date:  2017-05-25       Impact factor: 4.267

Review 4.  Mental health in 2020 for men who have sex with men in the United States.

Authors:  Abigail W Batchelder; Steven Safren; Avery D Mitchell; Ivan Ivardic; Conall O'Cleirigh
Journal:  Sex Health       Date:  2017-02       Impact factor: 2.706

5.  Psychometric validity of the distress thermometer and problem check list in ART-naïve HIV infected patients in Northern Nigeria.

Authors:  Victor Olisah Obiajulu; Tajudeen Abiola; Christopher Okpataku Izehinosen; Reginald O Obiako; Ishaq Audu Aveka; Bashir Yakasai Adam; Taiwo Sheikh Lateef
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

6.  Depressive symptoms, physical symptoms, and health-related quality of life among older adults with HIV.

Authors:  Blair Olson; Wilson Vincent; Jaimie P Meyer; Trace Kershaw; Kathleen J Sikkema; Timothy G Heckman; Nathan B Hansen
Journal:  Qual Life Res       Date:  2019-08-24       Impact factor: 4.147

7.  Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat.

Authors:  Alexandra Mangili; Julian Falutz; Jean-Claude Mamputu; Miganush Stepanians; Brooke Hayward
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.